Medical Equipment

Breast Cancer Diagnostics Market 2025–2029: Strategic Opportunities and Growth Insights

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the breast cancer diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Breast Cancer Diagnostics Market Now And By 2029?

The breast cancer diagnostics market size has experienced robust growth in recent years. Projections indicate an expansion from $4.68 billion in 2024 to $5 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion has been driven by factors such as awareness and screening campaigns, widespread mammography screening, continuous technological advancements, the availability of genetic testing, and a comprehensive multidisciplinary approach.

The market for breast cancer diagnostics is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $6.81 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the forecast period include the rise of personalized medicine, advancements in liquid biopsies, the adoption of 3D mammography (tomosynthesis), the integration of AI and machine learning, and the increasing use of telemedicine and remote consultations. Key trends characterizing the forecast period encompass breakthroughs in imaging technologies, the evolution of personalized medicine, the development of liquid biopsies, and the application of AI and machine learning.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

Which Long-Term Drivers Are Expected To Sustain The Breast Cancer Diagnostics Market?

The rising occurrence of breast cancer will necessitate more diagnostic equipment, which, in turn, will elevate the demand for the breast cancer diagnostics market. Breast cancer stands as the most common cancer, impacting 2.1 million women annually and accounting for the highest number of cancer-related deaths in women. The objective of early diagnosis is to enhance the percentage of breast cancers identified at an initial stage, allowing for more successful care and a reduction in the risk of death from breast cancer. For instance, in January 2022, the American Cancer Society, a US-based health organization focused on cancer elimination, estimated that roughly 287,850 new cases of invasive breast cancer and 51,400 occurrences of DCIS would be diagnosed in women in the United States in 2022, with an expected 43,250 fatalities attributed to breast cancer. Hence, the increasing incidence of breast cancer is projected to propel the growth of the breast cancer diagnostics market.

How Is The Breast Cancer Diagnostics Market Classified By Different Segments?

The breast cancer diagnosticsmarket covered in this report is segmented –

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Subsegments:

1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

How Are Industry Trends Steering The Expansion Of The Breast Cancer Diagnostics Market?

Technological progress represents a significant trend within the breast cancer diagnostics market. A range of new techniques have been developed that hold promise for use in diagnosing and treating breast cancer. For example, 3D mammography, also known as breast tomosynthesis, acquires images around the breast from different angles and transforms them into a 3-D model. In September 2022, Niramai, an Indian Health-Tech company, unveiled an innovative solution named Thermalytix. This is an automated instrument for breast cancer screening and diagnosis that integrates thermal imaging and AI.

Who Are The Primary Market Leaders In The Breast Cancer Diagnostics Market?

Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Breast Cancer Diagnostics Market?

North America was the largest region in the breast cancer diagnostics market in 2024. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp

Browse Through More Reports Similar to the Global Breast Cancer Diagnostics Market 2025, By The Business Research Company

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Antibody Drug Conjugates Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795